← Back to Search

Group 2 cohort: Elite Older Athletes (EOA) for Aging

N/A
Waitlist Available
Led By John C Newman, MD PhD
Research Sponsored by Buck Institute for Research on Aging
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2
Awards & highlights

Summary

This study is to investigate characteristics of muscle, blood, and urine samples from older adults (ages 65-80) who are either sedentary or athletes performing at an elite level for their age. This observational study will include bio-specimen collection, as well as physical and cognitive function testing and body composition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Muscle cellular aging - single cell transcriptomics
Muscle cellular aging - spatial transcriptomics
Secondary study objectives
Blood cell gene expression
Blood cell immune function
Blood metabolites
+11 more
Other study objectives
Body composition - BIA
Body composition - muscle mass
Cognitive function - Montreal Cognitive Assessment
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group 2 cohort: Elite Older Athletes (EOA)Experimental Treatment1 Intervention
This cohort will include healthy older adults, aged 65y or over, who are elite athletes for their age (determined by interview and VO2max)
Group II: Group 1 cohort: Healthy Older Adults (HOA)Experimental Treatment1 Intervention
This cohort will include healthy older adults, aged 65y or over, who participate in less than 60 minutes of structured exercise each week.

Find a Location

Who is running the clinical trial?

Buck Institute for Research on AgingLead Sponsor
3 Previous Clinical Trials
470 Total Patients Enrolled
1 Trials studying Aging
30 Patients Enrolled for Aging
John C Newman, MD PhDPrincipal InvestigatorBuck Institute
~53 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top